June 3, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Swift Biosciences and Arbor Biosciences Partner on Targeted NGS Workflows for Coronavirus

ANN ARBOR, Mich. June 3, 2020 /PRNewswire/ — Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift’s patented Adaptase® technology... Read more

May 28, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

Swift Biosciences Enables COVID-19 Surveillance With NGS of Low Titer SARS-CoV-2 Specimens

ANN ARBOR, Mich. – May 28, 2020 — Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has announced the release of its Swift Normalase™ Amplicon Panel (SNAP) SARS-CoV-2 kit. Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift’s... Read more

May 28, 2020 Bio/Pharma/CRO Clinical Research/Diagn. Microscopy

Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia

Basel, 28 May 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA) to evaluate the safety and efficacy of Actemra/RoActemra plus the investigational antiviral remdesivir, versus placebo plus remdesivir in hospitalised patients with severe COVID-19 pneumonia, in collaboration with Gilead Sciences, Inc.  Read more

May 26, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

Leica Biosystems and Bio-Techne Announce European Launch of the CE-IVD RNAscope in Situ Hybridization Detection Kit

MAY 26, 2020 The CE-IVD marked system will enable diagnostic pathologists with new applications MINNEAPOLIS, May 26, 2020 /PRNewswire/ — Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities and Leica Biosystems, a global leader in workflow solutions and automation, are proud to announce... Read more

May 22, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

Genomics insights generated through sequencing an individual’s DNA play a critical role in personalised healthcare and clinical diagnostics of the future Roche is committed to developing a nanopore sequencer with the aim of providing the healthcare community and ultimately patients with faster and more accurate medical information to predict risk and detect disease This investment... Read more

May 14, 2020 Clinical Research/Diagn. Informatics & Software PR/Corporate

Clear Labs Raises $18M; Plans to Expand Application of Automated Next-Generation Sequencing Platform to COVID-19 Diagnostics

Company’s novel characterizing diagnostic could significantly improve testing rates, results, and ability to trace the virus MENLO PARK, CALIF. (PRWEB) MAY 14, 2020 Clear Labs, providers of the only automated and intelligent diagnostic NGS platform, today announced the raise of a $18M strategic round of funding led by Redmile Group, as well as existing investors including... Read more

May 14, 2020 Clinical Research/Diagn. PAI Top-10

Roche to present first clinical data on novel anti-TIGIT cancer immunotherapy tiragolumab at ASCO

Phase II CITYSCAPE trial shows promising results adding tiragolumab to Tecentriq in people with PD-L1-positive metastatic non-small cell lung cancer Full results will be presented in an oral abstract session at the ASCO20 Virtual Scientific Program organised by the American Society of Clinical Oncology (ASCO) Basel, 14 May 2020 – Roche (SIX: RO, ROG; OTCQX:... Read more